You may think you know how much Intel is struggling, but the reality is worse. The once-mighty American innovation powerhouse is losing market share in multiple areas that are critical to its ...
A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.
Explore our handpicked selection of the "Best Processor Phones under 20,000," thoughtfully curated by our experts. These smartphones feature powerful chipsets that deliver seamless performance for ...